. NO synthesis inhibitor, L-NAME (10 mM) and the guanylate cyclase inhibitor, methylene blue (10 mM) did partly antagonize NA-evoked contractions and were without effect on EFSinduced contractions. Thus, the antivasoconstrictor effect of pinacidil on RA is partly endothelium-dependent and probably mediated via cGMP-dependent NO-pathway. 
INTRODUCTION
Pinacidil, a prevously studied potassium channel opener (PCO), is a potent antihypertensive agent in animals and humans. PCOs are a class of drugs that has the ability to open K + channels and to produce hyperpolarization and relaxation of vascular smooth muscle cells. Recently they have been used in hyperpolarizing cardioplegia which has a protective role on endothelial function in coronary microcirculation (Yang and He, 2005) . Mechanism of action of pinacidil isn't fully determined and involves opening of various types of K + channels (Bychkov et al., 1997) . However, pinacidil has some additional K + -channelindependent mechanism(s), most probably stimulation of the forward mode of Na + -Ca 2+ exchanger (Stojnic et al., 2007; Tsang et al., 2003) .
Some studies have shown that pinacidil produces endothelium-dependent vasodilatation, since removal of endothelium reduced in vivo the maximal relaxation of dog coronary arteries by 75 % (Ghaleh et al., 1995) . Deka et al. (1998) have shown that treatment of endothelium-intact rings of goat coronary artery with the NO synthesis inhibitor L-NAME or the guanylate cyclase inhibitor, methylene blue resulted in a marked inhibition in the relaxant responses to pinacidil. There are also studies, performed on animals, which supports opinions that pinacidilinduced vascular relaxation is a direct effect mediated by a novel, still unknown mechanisms (Quast, 1993) .
The effect of pinacidil on neurogenic contractions of radial artery (RA) hasn't been studied yet. Since neurogenic contractions can contribute to the development of vascular spasm, the current study was performed in order to investigate the mechanism of the antivasoconstrictor effect of pinacidil on neurogenic contractions of RA and to study whether this effect is endotheliumdependent.
MATERIALS AND METHODS
Remaining segments of left RA (n = 67) were taken from male patients during bypass operation. Only arteries without macroscopic evidence of atherosclerosis were used. Research has been carried out in accordance to the Declaration of Helsinki (2000) of the World Medical Association. The vessel segments were taken within 10 min after clamping blood flow, placed in cold (4 o C) Krebs-Ringer-bicarbonate solution (mmol/L: NaCl 120, KCl 5, CaCl 2 2.5, MgSO 4 1.2, NaHCO 3 25, KH 2 PO 4 1.2, glukose 11, Na 2 EDTA 0.032) and taken to the lab immediately.
Artery segment preparations
The artery segments were dissected from connective tissue and cut into 3 mm rings. From each patient were obtained 2 -3 rings. When necessary, the endothelium was removed mechanically by rubbing it with a steel wire. Vessels' rings were mounted on two stainless steel wires in a 10 mL organ bath with KrebsRinger-bicarbonate solution (37 o C, pH 7.4) aerated with 95% O 2 and 5% CO 2 . One of the wire hooks was connected to the transducer (F30; Hugo Sachs, Freiburg, Germany), amplifier (301; Hugo Sachs, Freiburg, Germany) and recording system (R60; Rikadenki, Tokyo, Japan) that recorded changes in isometric tension. The other wire hook was attached to the displacement unit allowing fine adjustments of passive tension.
The preparations were equilibrated for 60 min and washed every 15 min with fresh buffer during this period. All vessels were then gradually passively stretched to an optimal resting tension, determined in a way previously described by our group (Stojnic et al., 2007) .
Experimental procedure
After 15 min of equilibration, the presence of functional endothelium was assessed. Rings were precontracted with phenylephrine (10 mM) and acetylcholine (20 mM) was added to the organ bath. If the maximal relaxant effect was more than 80% of the initial contraction, we considered functional endothelium to be present.
Contractions of the RA evoked by EFS:
Intramural nerves were stimulated using two platinum wire electrodes. The repetitive transmural EFS was carried out at 20 Hz with square wave pulses of 0.3-ms duration and supramaximal voltage. Trains of pulses of 3-s duration were delivered from a Grass S44 electronic stimulator at 2 min intervals (12, 13) .
The preparations were allowed to stabilize for at least 30 min until twitch responses became consistent, before addition of drugs. The concentrationresponse curve was constructed by addition of pinacidil directly to the bathing solution in a cumulative way, taking the amplitude of response measured immediately before the addition of a drug as a control (100%). Higher concentrations of pinacidil were added only when the previous concentration has produced an equilibrium response.
In separate experiments, after twitch responses became consistent, the enzyme inhibitor (L-NAME, methylene blue-MB) was added into the bathing solution at least 20 min before exposure to pinacidil. Addition of these drugs did not modify the basal contractions of RA (n = 5) evoked by EFS. The amplitude of the response measured immediately before addition of pinacidil was taken as the control (100%).
In order to confirm that EFS-induced contractions are mediated by neurotransmitter release from the sympathetic nerves, tetrodotoxin (1 mM) or phentolamine (1 mM) was added into the bathing solution, 20 min before applying EFS.
Contraction of the RA evoked by exogenous NA:
In a separate series of experiments, preparations not subjected to EFS were challenged repeatedly, for 2 min at 45-min intervals, with NA (10 mM) to produce contractions similar in shape (maximal amplitude and slope) to those evoked by EFS. After achieving the maximal amplitude of the phasic contraction induced by exogenous NA, the arterial preparation was washed to prevent the development of sustained (tonic) contractions. Pinacidil was added into the medium for 10 min, and the preparation was rechallenged to NA. The control exposure to NA was taken as 100% response. The antivasoconstrictor effect of pinacidil was then investigated in the presence of the enzyme inhibitor (L-NAME, MB). These drugs alone did not modify the basal contractions of RA (n = 4) evoked by exogenous NA.
Data and statistical analysis
The results are expressed as mean ± standard error of mean (S.E.M.); n refers to the number of trials. The least squares method was used for calculating linear regression. The concentration of pinacidil producing 50% of the maximum response (EC 50 ) was determined graphically for each curve by linear interpolation. The EC 50 values are presented as pEC 50 (-log EC 50 ). The statistical difference between means was determined by one-way ANOVA and Student's ttest, a value of p<0.05 was considered statistically significant.
Drugs
The following drugs were used: (R)-(-)-phenylephrine hydrochloride, Lnoradrenaline (NA), tetrodotoxin, phentolamine, pinacidil, N-nitro-L-argininemethyl ester hydrochloride (L-NAME) and methylene blue (MB) (Sigma-Aldrich Inc., St. Louis, MO, USA). Pinacidil was dissolved in 0.01 N HCl and all other drugs were dissolved in distilled water. Previous experiments have shown that the solvents used had no effect on preparations at the concentrations applied. All drugs were added directly to the bath in a volume of 100 mM and the concentrations given are the calculated final concentrations in the bath solution.
RESULTS

Effects of tetrodotoxin and a-adrenoceptor blockade on EFS induced contractions
Tetrodotoxin (1 mM) completely abolished the EFS evoked contractions of RA (n= 4). Phentolamine (1 mM) reduced the EFS evoked contractions of RA (92± 2%, n= 4). Data are not shown.
Effects of pinacidil on EFS-evoked contractions and exogenous NA-induced contractions of RA
Original recording of the inhibitory effect of pinacidil on EFS-and NAevoked contractions of RA with endothelium is shown in Figure 1A Figure 1 Representative experiments showing antivasoconstrictor effect of pinacidil in the human radial artery. To asses the endothelial integrity of the preparation acetylcholine (Ach) was used. Relaxation of phenylephrine (Ph) precontracted arteries greater than 80 % was considered to indicate a state of endothelial preservation. Contractions of RA were evoked by electrical field stimulation (EFS, 20 Hz -A) or exogenously applied noradrenaline (NA, 10 mM, black triangle -B). After 3-min period NA-evoked contraction was ceased by wash-out (arrow). Cumulative concentrations of pinacidil (black circle) were added to the organ-bath was no difference (p>0.05) in EC 50 values and maximal response to pinacidil (E max ) in the inhibition of neurogenic and NA-evoked contractions (Fig. 2) . Pinacidil (10 nM-100 mM) produced a concentration-dependent inhibition of both EFS-induced contractions (EC 50 = 1.52±0.10 mM, E max = 94 ± 4%, n = 12) and contractions evoked by exogenous NA (EC 50 = 1.16 ± 0.10 mM, E max = 96 ± 3 %, n = 7) of the RA.
Effects of L-NAME and methylene blue on pinacidil-induced inhibition of neurogenic contractions and contractions evoked by exogenously applied
NA on the RA L-NAME (10-100 mM) did not antagonize the inhibitory action of pinacidil on neurogenic contractions elicited by EFS (EC 50 = 1.12 ± 0.09 mM for control, n = 5; 0.76 ± 0.12 mM) in the presence of 10 mM L-NAME (n = 5; 1.18 ± 0.09 mM), in the presence of 100 mM L-NAME (n = 5; p>0.05) (data not shown). However, L-NAME (10 mM) partially antagonizes the inhibitory action of pinacidil (10 mM) on contractions evoked by exogenously applied NA in RA with endothelium (% of control contraction: 22 ± 3 % in the absence vs. 41 ± 3 % in the presence of L-NAME, p<0.05, n = 5) (Fig 3A and Table 1 ).
MB (10 -30 mM) was also without effect on pinacidil-induced inhibition of neurogenic contractions of RA with endothelium (EC 50 = 1.08 ± 0.12 mM, n = 5 vs. 0.96 ± 0.10 mM, n = 5, in the presence of 10 mM MB and 0.80 ± 0.12 mM, n = 5, in the presence of 30 mM MB, p>0.05, all) (data not shown). Similarly to previous results, MB ( contraction: 23 ± 3 % in the absence vs. 56 ± 2 % in the presence of MB, p<0.05, n = 5) (Fig 3B and Table 1 ). 
DISCUSSION
It is well established that EFS of perivascular nerve terminals on isolated blood vessels releases various neurotransmitters and co-transmitters (noradrenaline, ATP, neuropeptide Y) which contribute to the development of contractions (Smyth et al., 2000) . To validate the effect of transmural EFS on the isolated blood vessels, we applied tetrodotoxin (1 mM) in a concentration that selectively paralyzes nerve endings. The confirmation of the neurogenic nature of the contraction induced by EFS in our experiments was obtained by 100 % inhibition of EFS-induced contractions of the RA by tetrodotoxin. In order to further define the site of action/mechanisms of EFS-induced contractions of the RA we used phentolamine. A significant reduction of EFS-induced contraction by phentolamine (>80 %) indicates that NA released from perivascular sympathetic nerve endings acts on vascular, postjunctional a-adrenoceptors. He and Yang (1998) have shown that predominant adrenoreceptors in human RA are a 1 and to a lesser extent a 2 .
Histological studies have identified nerve fibres in the tunica adventitia of human RA (Barry et al., 2003) . Recently, it has been shown by our group of authors (Stojnic et 2+ channels, influx of extracellular Ca 2+ and release of neurotransmitters. Depolarization also produces activation of K V channels, while an increase in intracellular Ca 2+ is followed by opening of K Ca channels, efflux of K + and hyperpolarization of the cell. These subsequent events may act as a negative feedback mechanism in neurotransmitter release (Teramoto, 2006 , Pagan et al., 2009 .
PCOs are a class of drugs that has the ability to open K ATP channels to produce hyperpolarization and relaxation of vascular smooth muscle cells. Recently, they have been used in hyperpolarizing cardioplegia which has a protective role on endothelial function in coronary microcirculation (Yang and He, 2005) . Pinacidil is a previously studied PCO whose mechanism of action is very well established and for this reason it is a useful pharmacological tool for the study of K + channels (Quast, 1993; Bychkov et al., 1997) . We have shown previously that pinacidil is a potent vasodilator of human RA precontracted with phenylephrine, and it seems that the mechanism of action of pinacidil on the RA involves activation of smooth muscle glibenclamide-and TEA-sensitive K + channels, but not 4-aminopyridine (4-AP) sensitive channels (Stojnic et al., 2007) . It was previously shown in different animal models that pinacidil has inhibitory effects on both EFS-and NA-evoked contractions (Cai et al., 1994) . This is the first study of the inhibitory effects of pinacidil on electrically-evoked contractions of RA. The pinacidil-induced endothelium-independent inhibition of neurogenic contractions of RA are of a potency comparable to those of the rat ileum (Davies et al., 1996) and rabbit portal vein (Gojkovic-Bukarica and Kazic, 1999). When contractions were evoked by exogenously applied NA sensitivity of RA to the inhibitory action of pinacidil was significantly greater than those of the rabbit portal vein, thus suggesting that it could have a therapeutic potential in the prevention of spasm. Our finding that the effect of pinacidil is partly endothelium-dependent is comparable to results of Ghaleh et al. (1995) . However, our group has previously shown that the vasodilatatory effect of pinacidil on RA is not endotheliumdependent, but in that study a different experimental protocol was used.
L-NAME is a non-selective inhibitor of NO-syntase, which inhibits all three isoforms of this enzyme responsible for production of NO (Handy and Moore, 1998) . MB is a well established inhibitor of guanilate-cyclase, which produces cGMP. Neither of these enzyme inhibitors did affect the inhibitory effect of pinacidil on EFS-evoked contractions of RA. However, when contractions of RA were evoked by exogenously applied NA acting postsynaptically, these two enzyme inhibitors applied in a low concentration (10 mM) did partly antagonize the inhibitory effect of pinacidil suggesting NO involvement. Deka et al. (1998) have also shown that vasodilation produced by pinacidil in the goat coronary artery could partly be inhibited by application of L-NAME and MB. This result supports our observation that cGMP-dependent NO-pathway plays a role in the inhibition of NA-evoked contractions of RA.
Our results show that pinacidil is a potent antivasoconstrictor agent on RA and that it can be considered as a potential drug in the prevention of RA spasm. Its mechanism of antivasoconstrictor action involves an endothelium-dependent component with increased release of NO and cGMP as the second messenger.
